Sivan Weiss

722 total citations
9 papers, 556 citations indexed

About

Sivan Weiss is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Sivan Weiss has authored 9 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Sivan Weiss's work include Asthma and respiratory diseases (6 papers), Respiratory and Cough-Related Research (4 papers) and Eosinophilic Esophagitis (2 papers). Sivan Weiss is often cited by papers focused on Asthma and respiratory diseases (6 papers), Respiratory and Cough-Related Research (4 papers) and Eosinophilic Esophagitis (2 papers). Sivan Weiss collaborates with scholars based in Israel, United States and Belgium. Sivan Weiss's co-authors include James Zangrilli, Matthew Germinaro, Leif Bjermer, Jorge Máspero, Catherine Lemière, Guy Brusselle, Tzippy Shochat, Jerry S. Wolinsky, David Ladkani and Ofer Spiegelstein and has published in prestigious journals such as CHEST Journal, Journal of the Neurological Sciences and Cephalalgia.

In The Last Decade

Sivan Weiss

9 papers receiving 547 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sivan Weiss	442	315	133	104	97	9	556
S. Kundu	486 1.1×	428 1.4×	41 0.3×	133 1.3×	21 0.2×	20	576
Tiffany L Bamford	228 0.5×	229 0.7×	49 0.4×	44 0.4×	53 0.5×	9	386
D. Häfner	251 0.6×	139 0.4×	101 0.8×	148 1.4×	23 0.2×	12	393
Satoko Takei	147 0.3×	152 0.5×	126 0.9×	14 0.1×	34 0.4×	21	430
Hajo Jongepier	305 0.7×	187 0.6×	77 0.6×	56 0.5×	26 0.3×	9	453
Helen Neighbour	307 0.7×	151 0.5×	81 0.6×	151 1.5×	58 0.6×	24	423
E. Philpot	936 2.1×	336 1.1×	16 0.1×	973 9.4×	87 0.9×	51	1.1k
Khuder Alagha	313 0.7×	266 0.8×	150 1.1×	49 0.5×	54 0.6×	13	473
Kirsten Janssen	204 0.5×	176 0.6×	53 0.4×	19 0.2×	22 0.2×	8	281
Grazyna Pinis	350 0.8×	219 0.7×	56 0.4×	105 1.0×	32 0.3×	8	422

Countries citing papers authored by Sivan Weiss

Since Specialization

Citations

This map shows the geographic impact of Sivan Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sivan Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sivan Weiss more than expected).

Fields of papers citing papers by Sivan Weiss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sivan Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sivan Weiss. The network helps show where Sivan Weiss may publish in the future.

Co-authorship network of co-authors of Sivan Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Sivan Weiss. A scholar is included among the top collaborators of Sivan Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sivan Weiss. Sivan Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Greenblatt, David J., et al.. (2020). The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel Neuroimmunomodulator. Clinical Pharmacology in Drug Development. 9(8). 1015–1024. 3 indexed citations

Cohen‐Barak, Orit, Sivan Weiss, Michèle Rasamoelisolo, et al.. (2018). A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects. Cephalalgia. 38(13). 1960–1971. 39 indexed citations

Brusselle, Guy, Janice Canvin, Sivan Weiss, Shawn X. Sun, & Roland Buhl. (2017). Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy. ERJ Open Research. 3(3). 4–2017. 16 indexed citations

Brusselle, Guy, Matthew Germinaro, Sivan Weiss, & James Zangrilli. (2017). Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils. Pulmonary Pharmacology & Therapeutics. 43. 39–45. 89 indexed citations

Bjermer, Leif, Catherine Lemière, Jorge Máspero, et al.. (2016). Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels. CHEST Journal. 150(4). 789–798. 330 indexed citations

Virchow, J. Christian, James Zangrilli, Sivan Weiss, & Stephanie Korn. (2016). Reslizumab (RES) in patients (pts) with inadequately controlled asthma and elevated blood eosinophils (EOS): Analysis of two phase 3, placebo-controlled trials. OA1797–OA1797. 4 indexed citations

Canvin, Janice, Robert Noble, Ratko Djukanović, et al.. (2016). LATE-BREAKING ABSTRACT: Early identification of responders to reslizumab at 16 weeks using an algorithm derived from the pivotal clinical studies of severe eosinophilic asthma (SEA) patients. OA2998–OA2998. 3 indexed citations

Shram, Megan J., Orit Cohen‐Barak, Bijan Chakraborty, et al.. (2015). Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users. Journal of Clinical Psychopharmacology. 35(4). 396–405. 42 indexed citations

Wolinsky, Jerry S., Tzippy Shochat, Sivan Weiss, & David Ladkani. (2009). Glatiramer acetate treatment in PPMS: Why males appear to respond favorably. Journal of the Neurological Sciences. 286(1-2). 92–98. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact